Blume-Jensen Peter
Reporting owner on Forms 3, 4 and 5, CIK 1950499.
- In the filer group Blume-Jensen Peter
Blume-Jensen Peter reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ACRV · Acrivon Therapeutics, Inc.CIK 1781174 | director, officer (President and CEO) | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ACRV · Acrivon Therapeutics, Inc.Common Stock | 2026-11-17 | S sold | -1,276 | $1.45 | 2,228,776 | Form 4 |
| ACRV · Acrivon Therapeutics, Inc.Common Stock | 2026-11-17 | S sold | -504 | $1.45 | 385,355 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000905148-26-005050 | Acrivon Therapeutics, Inc. | 2026-11-19 |